Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresis

Area of Science:

• Cardiovascular Physiology
• Endocrinology
• Renal Physiology

Background:

• Angiotensin-(1-7) is an emerging component of the renin-angiotensin system (RAS).
• It exhibits actions distinct from, yet related to, angiotensin II.
• Its formation can bypass angiotensin II, involving specific enzymes.

Purpose of the Study:

• To elucidate the role and mechanisms of angiotensin-(1-7) within the RAS.
• To investigate the enzymatic pathways involved in angiotensin peptide interconversion.
• To understand the physiological effects and receptor interactions of angiotensin-(1-7).

Main Methods:

• Analysis of enzymatic pathways for angiotensin peptide metabolism.
• Investigation of angiotensin-(1-7) interactions with other vasoactive peptides like bradykinin and atrial natriuretic peptide.
• Assessment of angiotensin-(1-7)'s effects on prostaglandin and nitric oxide synthesis.
• Evaluation of angiotensin-(1-7)'s impact on renal tubular function and blood pressure.

Main Results:

• Angiotensin-(1-7) can be formed directly from angiotensin I, independent of angiotensin II.
• Key enzymes like neprilysin and prolyl-endopeptidase 24.26 regulate this pathway.
• Angiotensin-(1-7) promotes vasodilator release (prostaglandins, nitric oxide) and augments bradykinin's actions.
• It influences renal sodium and bicarbonate handling, decreases Na+-K+-ATPase activity, and induces diuresis.
• These actions collectively contribute to a blood pressure-lowering effect.

Conclusions:

• Angiotensin-(1-7) plays a significant, blood pressure-lowering role in the RAS.
• Its formation and actions are intricately linked with other vasoactive peptide systems.
• Evidence suggests angiotensin-(1-7) mediates its effects through a unique receptor, distinct from AT1 and AT2 subtypes.